Bioactivation, toxicokinetics and acute effects of chloroform in fisher 344 and Osborne Mendel male rats

Journal of Applied Toxicology

Volumn 24, Issue 3, 2004, Pages 203-210

  Gemma, Simonetta ^a   Testai, Emanuela ^a   Chieco, Pasquale ^b   Vittozzi, Luciano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chloroform; F344 rats; Hepatic and renal bioactivation; Osborne Mendel rats; Toxicokinetics

Indexed keywords

CARBON DIOXIDE; CARCINOGEN; CHLOROFORM; PHOSGENE; RADICAL;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CARCINOGENESIS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL MODEL; EXPIRATORY FLOW; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CANCER; KIDNEY MICROSOME; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TOXICOKINETICS;

ANIMALS; CHLOROFORM; KIDNEY; LIVER; MALE; RATS; RATS, INBRED F344; SOLVENTS; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

MARTES PENNANTI;

EID: 3042675430     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.973     Document Type: Article

References (36)

1. Ade P, Guastadisegni C, Testai E, Vittozzi L. 1994. Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. J. Biochem. Toxicol. 9: 289-295.
2. Ahmadizadeh M, Kuo CH, Hook JB. 1981. Nephrotoxicity and hepatotoxicity of chloroform in mice: effect of deuterium substitution. J. Toxicol. Environ. Health 8: 105-111.
3. Ammann P, Laethem CL, Kedderis GL. 1998. Chloroform-induced cytolethality in freshly isolated male B6C3F1 mouse and F-344 rat hepatocytes. Toxicol. Appl. Pharmacol. 149: 217-225.
4. Branchflower RV, Pohl LR. 1981. Investigation of the mechanism of the potentiation of chloroform-induced hepatotoxicity and nephrotoxicity by methyl n-butyl ketone. Toxicol. Appl. Pharmacol. 61: 407-413.
5. Chiu N, Orme-Zavaleta J, Chiu A, Chen C, DeAngelo A, Brattin W, Blancato J. 1996. Characterization of cancer risk associated with exposure to chloroform. Environ. Carcinogen. Ecotoxicol. Rev. C14: 81-104.
6. 3 metabolites to microsomal phospholipids. Chem. Biol. Interact. 85: 229-242.
7. De Curtis V, Gemma S, Sbraccia M, Testai E, Vittozzi L. 1994. The contribution of electrophilic and radicalic intermediates to phospholipid adducts formed by halomethanes in vivo. J. Biochem. Toxicol. 9: 305-310.
8. Di Consiglio E, De Angelis G, Testai E, Vittozzi L. 2001. Correlation of a specific mitochondrial phospholipid adduct with phosgene and chloroform acute toxicity. Toxicology 159: 43-53.
9. Docks EL, Krishna G. 1976. The role of gluthatione in chloroform-induced hepatotoxicity. Exp. Mol. Pathol. 24: 13-22.
10. Folch J, Lees M, Sloane-Stanley GM. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
11. Gemma S, Ade P, Sbraccia M, Testai E, Vittozzi L. 1996a. In vitro quantitative determination of phospholipid adducts of chloroform intermediates in hepatic and renal microsomes from different rodent strains. Environ. Toxicol. Pharmacol. 2: 233-242.
12. 3 bioactivation, toxicokinetics, toxicity and induced compensatory cell proliferation in B6C3F1 male mice. Toxicol. Appl. Pharmacol. 141: 394-402.
13. Golden RJ, Holm SE, Robinson DE, Julkunen PH, Reese EA. 1997. Chloroform mode of action: Implications for cancer risk assessment. Reg. Toxicol. Pharmacol. 26: 142-155.
14. Hogan MD, Chi PY, Hoel DG, Mitchell TJ. 1979. Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates. J. Environ. Pathol. Toxicol. 2: 873-887.
15. Jorgenson TA, Meierhenry EF, Rushbrook CJ, Bull RJ, Robinson M. 1985. Carcinogenicity of chloroform in drinking water to male Osborne Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5: 760-769.
16. Larson JL, Wolf DC, Butterworth BE. 1994a. Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage. Fundam. Appl. Toxicol. 23: 537-543.
17. Larson JL, Wolf DC, Butterworth BE. 1994b. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by gavage in corn oil vs. ad libitum in drinking water. Fundam. Appl. Toxicol. 22: 90-102.
18. Melnick RL, Kohn MC, Dunnick JK, Leininger JR. 1998. Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes. Toxicol. Appl. Pharmacol. 148: 137-147.
19. Miyagawa M, Katsuta O, Chida T, Toyota N, Tsuchitani M, Yoshikawa K, Fujii O. 1998. Occurrence of toxicity and cell proliferation after a single gavage administration of chloroform to male F344 rats. J. Toxicol. Environ. Health A57: 415-429.
20. NCI. 1976. Report on carcinogenesis bioassay of chloroform. Natl. Tech. Inf. Serv. PB-264018/AS. NCI: London.
21. Pohl LR, Martin JL, George JW. 1980. Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem. Pharmacol. 29: 3271-3276.
22. Reitz RH, Fox TR, Quast JF. 1982. Mechanistic considerations for carcinogenic risk estimation: chloroform. Environ. Health Perspect. 46: 163-168.
23. Robbiano L, Meretto E, Migliazzi Morando A, Pastore P, Brambilla G. 1998. Increased frequency of micronucleated kidney cells in rats exposed to halogenated anaesthetics. Mutak. Res. 413: 1-6.
24. Rossi S, Gemma S, Fabrizi L, Testai E, Vittozzi L. 1999. Time dependence of chloroform-induced metabolic alterations in the liver and kidney of B6C3F1 mice. Arch. Toxicol. 73: 387-393.
25. Rouser G, Siakotos AN, Fleischer S. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1: 85-89.
26. Schutte B, Reynders MMJ, Bosman FT, Blijham C. 1987. Effect of tissue fixation on anti-bromodeoxyuridine immunohistochemistry. J. Histochem. Cytochem. 35: 1343-1345.
27. Smith JH, Hook JB. 1984. Mechanism of chloroform nephrotoxicity III. Renal and hepatic metabolism of chloroform in mice. Toxicol. Appl. Pharmacol. 73: 511-524.
28. Smith JH, Maita K, Sleight SD, Hook JB. 1983. Mechanism of chloroform nephrotoxicity I. Time course of chloroform toxicity in male and female mice. Toxicol. Appl. Pharmacol. 70: 467-479.
29. Smith JH, Hewitt WR, Hook JB. 1985. Role of intrarenal biotransformation in chloroform induced nephrototoxicity in rats. Toxicol. Appl. Pharmacol. 79: 166-174.
30. 2H)-chloroform. Chem. Biol. Interact. 37: 207-217.
31. Templin MV, Jamison KC, Wolf DC, Morgan KT, Butterworth BE. 1996. Comparison of chloroform-induced toxicity in the kidney, liver and nasal passages of Osborne-Mendel and F344 rats. Cancer Lett. 104: 71-78.
32. Testai E, Vittozzi L. 1986. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. Chem. Biol. Interact. 59: 157-171.
33. Testai E, Di Marzio S, Vittozzi L. 1990. Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice. Toxicol. Appl. Pharmacol. 104: 496-503.
34. 3 carcinogenicity. Toxicol. Appl. Pharmacol. 114: 197-203.
35. Vittozzi L, Gemma S, Sbraccia M, Testai E. 2000. Comparative characterization of chloroform metabolism and toxicokinetics in rodent strains differently susceptible to chloroform carcinogenicity. Environ. Toxicol. Pharmacol. 8: 103-110.
36. WHO. 1994. IPCS Environmental Health Criteria 163. Chloroform. WHO: Geneva.